Bodd, the Australian 3D body-scanning technology company, has secured $15 million in fresh capital to accelerate its global expansion. The raise, led by US-based Blue Sky Capital with support from Ellerston Capital and several existing investors, pushes the company’s valuation to $110 million. The round exceeded its original $10 million target due to heightened investor demand, signaling strong confidence in the company’s strategic direction.
A Significant Capital Injection for Global Growth
The new funding will allow Bodd to establish a stronger international footprint, beginning with the opening of a US office and expansion initiatives in the UK and the Middle East. The company also plans to scale its workforce to 40 employees, a major jump from the 15 staff it had when it last raised $5 million in early 2023. This growth underscores the increasing traction of its technology among enterprise customers across industries such as aviation, defense, retail, and manufacturing.
Expanding Adoption Across Major Industries
Bodd’s platform is already used by a roster of high-profile clients, including United Airlines and Brooks Brothers in North America. Additional customers include Dublin-based workwear manufacturer Portwest, as well as Australian Defence Apparel, the New Zealand Defence Force, and Stewart & Heaton, a major uniform supplier. The company has demonstrated that accurate body-data capture can meaningfully improve operational efficiency for organizations that manage large uniformed workforces.
From Clothing Tech Startup to Data-Driven Platform
Founded in 2016 by Rob Fisher and David McLaughlin, the company originally focused on solving apparel sizing challenges through rapid body scanning. Its proprietary system creates what it calls a body “passport,” capturing a detailed digital profile in just 60 seconds to streamline fittings and reduce measurement errors. As the technology matured, Bodd began positioning itself as a broader data-tech company rather than a pure fashion-tech startup.
Moving Toward Healthtech and New Data Applications
The company now plans to deploy its scanners across Australian pharmacies starting in 2026, where body-data capture will support rising demand for weight-management treatments, including GLP-1 therapies. This move marks a major step into healthtech, a sector that relies heavily on consistent and precise physiological data. Bodd sees significant potential in enabling healthcare providers to track changes in patients with far more accuracy than traditional measurement methods.
Investor Confidence in High-Fidelity Body Data
CEO Rob Fisher said the oversubscribed round affirms the growing need for advanced body-data solutions in industries grappling with operational and decision-making complexity. He emphasized that artificial intelligence is driving a surge in demand for accurate datasets that can improve forecasts, optimize resource allocation, and inform product development. According to Fisher, Bodd’s high-quality data gives AI systems the reliability needed to perform effectively in real-world environments.
Strategic Support from Blue Sky Capital
Blue Sky Capital’s Steve Bellotti noted the extensive potential applications for Bodd’s data across both individual and population-level use cases. He highlighted the scalability of the technology, which can serve industries ranging from aviation and defense to retail and healthcare. Bellotti described the alignment between Bodd’s capabilities and the broader direction of data-driven operations as “strong and undeniable,” reinforcing the strategic rationale for leading the round.
A Technology with Broad Consumer and Professional Appeal
Beyond enterprise clients, Bodd has also demonstrated value in more personalized contexts, such as fitting tailored suits for prominent athletes including AFL players Mason Cox and Max Gawn. These use cases further illustrate how accurate digital measurements can enhance customer experience and reduce inefficiencies in apparel production. The company expects consumer-facing applications to continue expanding as the technology becomes more widely deployed.
Bodd’s latest funding round marks a pivotal moment for the company as it transitions from a specialized clothing-tech platform to a global leader in high-fidelity body-data analytics. With new capital, a growing client base, and a strategic push into healthtech, the company is positioning itself at the intersection of AI, measurement science, and operational efficiency. As demand for precision data accelerates across industries, Bodd is poised to play a central role in shaping how organizations and consumers capture and leverage information about the human body.
Source: StartupDaily